The Prognostic Significance of the Pan-Immune-Inflammation Value in Patients with Heart Failure with Reduced Ejection Fraction

QR Code

The Prognostic Significance of the Pan-Immune-Inflammation Value in Patients with Heart Failure with Reduced Ejection Fraction

<b>Objective:</b> We aimed to investigate the association between the pan-immune-inflammation value (PIV) and mortality in patients with heart failure with a reduced ejection fraction (HFrEF), along with clinical and biochemical parameters. <b>Methods</b>: In this retrospecti...

Full description

Saved in:

Bibliographic Details
Main Authors:	Emir Dervis, Idris Yakut, Duygu Inan
Format:	Article
Language:	English
Published:	MDPI AG 2025-06-01
Series:	Diagnostics
Subjects:	heart failure systolic inflammation prognosis biomarkers mortality
Online Access:	https://www.mdpi.com/2075-4418/15/13/1617
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Predictive value of pan-immune-inflammation value in the prognosis of adults with status epilepticus: a retrospective study
by: Jie Fu, et al.
Published: (2025-07-01)

Pan-Immune-Inflammation Value as a Prognostic Biomarker for Hepatocellular Carcinoma Patients Undergoing Hepatectomy
by: Fu H, et al.
Published: (2025-05-01)

Pan-immune-inflammation value in lung cancer: prognostic significance and implications for therapeutic guidance — a systematic review and meta-analysis
by: Shuailing Hong, et al.
Published: (2025-06-01)

Prognostic value of secondary hyperaldosteronism in patients with chronic heart failure with preserved ejection fraction
by: A. N. Shevelok
Published: (2021-07-01)

Biomarkers in the Pathogenesis of Heart Failure with Preserved as Well as Reduced Ejection Fraction: A Cross-sectional Study
by: Sowmiya Thiyagarajan, et al.
Published: (2025-06-01)

Prognostic significance of CD204 and IDO1 expression in esophageal tumors
by: O. V. Kovaleva, et al.
Published: (2021-07-01)

Prognostic significance of skin autofluorescence in patients undergoing maintenance hemodialysis
by: Darya Yu. Konovalova, et al.
Published: (2025-01-01)

Prognostic impact of pan-immune inflammation value in small-cell lung cancer treated with chemoradiotherapy and prophylactic cranial irradiation
by: Aybala Nur Ucgul, et al.
Published: (2025-07-01)

Value of CRP, albumin, and lymphocyte index in predicting survival of patients with gastrointestinal malignancies: a systematic review and meta-analysis
by: Hui Li, et al.
Published: (2025-07-01)

Transcriptomic-based analysis of endometrial tissues from adenomyosis patients reveals significant inflammation biomarkers: A bioinformatics study
by: Marni Sianturi, et al.
Published: (2025-07-01)

Prognostic Value of Pan-Immune Inflammation Value for Major Adverse Cardiac Events and Mortality in Patients with Aortic Stenosis After TAVI
by: Mehmet Nail Bilen, et al.
Published: (2025-05-01)

Metabolism-Related Genes SMOX and SUCLG2 as Immunological and Prognostic Biomarkers in Colorectal Cancer: A Pan-Cancer Analysis
by: Zuming Xiong, et al.
Published: (2025-06-01)

Prognostic significance of the pretreatment pan-immune-inflammation value in colorectal cancer patients: an updated meta-analysis
by: Jing Li, et al.
Published: (2025-07-01)

Atrial fibrillation in patients with dilated cardiomyopathy: prevalence, risk factors and prognostic significance
by: T. G. Vaikhanskaya, et al.
Published: (2023-11-01)

Patient compliance and physicians’ adherence to guidelines on heart failure with reduced ejection fraction
by: V. N. Larina, et al.
Published: (2020-04-01)

COMPARISON OF EJECTION FRACTION AND END VOLUMES OF THE LEFT VENTRICLE AS INDICATORS OF THE SEVERITY OF HEART FAILURE
by: Dinara Sh. Gazizova
Published: (2019-07-01)

Elevated central blood pressure, NT-proBNP and hs-cTnI in women with maternal complications of hypertensive disorders of pregnancy
by: Xolani B. Mbongozi, et al.
Published: (2025-12-01)

Molecular mechanisms of the development of atrial fibrillation in patients with type 2 diabetes mellitus: prognostic role of biomarkers of fibrosis and inflammation
by: V. A. Ionin, et al.
Published: (2022-11-01)

Prognostic value of myocardial flow reserve in patients with heart failure with preserved ejection fraction
by: K. V. Kopeva, et al.
Published: (2023-04-01)

Exploration of serum biomarkers in heart failure patients with preserved and reduced ejection fractions through analysis of heterogeneity
by: Qipeng Jin, et al.
Published: (2025-09-01)

Plasma metabolomics identifies signatures that distinguish heart failure with reduced and preserved ejection fraction
by: Fawaz Naeem, et al.
Published: (2025-08-01)

Effects of transluminal balloon angioplasty and stenting on the clinical course of ischemic chronic heart failure with preserved or reduced left ventricular ejection fraction: radionuclide 4D tomoventriculography data
by: N. V. Shashkova, et al.
Published: (2012-02-01)

The Importance of Pan‐Immune‐Inflammation Value Score in Locally Advanced Rectal Cancer
by: Mahmut Uçar, et al.
Published: (2025-07-01)

Predictor value of the inflammation biomarkers regarding the post-infarction remodeling of myocardium
by: M. V. Ivanov, et al.
Published: (2018-10-01)

Significance of inflammation markers in patients with coronary microvascular dysfunction and non-obstructive coronary artery disease
by: K. V. Kop’eva, et al.
Published: (2023-07-01)

The prognostic role of malnutrition in pulmonary hypertension
by: Arif Albulushi, et al.
Published: (2025-10-01)

Prospective Associations Between Salivary Biomarkers of Inflammation and Body Mass Index in Adolescents
by: Keri M. Kemp, et al.
Published: (2025-06-01)

The role of systemic inflammation in the pathogenesis of hyperkinetic disorder
by: Rauf F. Gasanov, et al.
Published: (2024-04-01)

PROGNOSTIC SIGNIFICANCE OF BIOMARKERS IN ORAL SQUAMOUS CELL CARCINOMA. REVIEW
by: A. V. Ignatova, et al.
Published: (2015-04-01)

ALGORITHM FOR THE TREATMENT OF PATIENTS WITH CHRONIC HEART FAILURE WITH REDUCED LEFT VENTRICULAR EJECTION FRACTION
by: E. V. Reznik, et al.
Published: (2018-03-01)

Prognostic Significance of the Integral Index of the Alcohol Situation in Assessing Regional Differences in Mortality from Cardiovascular Diseases in the Russian Federation
by: B. E. Gornyi, et al.
Published: (2022-03-01)

The Physical Activity in the Management of Heart Failure with Reduced Ejection Fraction A Review of Current Evidence and Recommendations
by: Natalia Smyl, et al.
Published: (2025-07-01)

Biomarkers in predicting mortality from cardiovascular events in patients with heart failure and an implanted cardioverter-defibrillator
by: N. N. Ilov, et al.
Published: (2023-10-01)

Prognostic value of TAPSE in patients with septic cardiomyopathy: a retrospective observational cohort study
by: Haiyun Liu, et al.
Published: (2025-07-01)

Performance of the neutrophil-to-lymphocyte ratio as a prognostic tool for survival in solid cancers
by: Irene Carrión-Barberà, et al.
Published: (2025-07-01)

Systemic S100A8/A9 in patients with moderate to severe acute ischemic stroke: Exploratory analysis of inflammation and functional outcome
by: Christoph Vollmuth, et al.
Published: (2025-08-01)

The relationship between gut microbiota, chronic systemic inflammation, and endotoxemia in patients with heart failure with preserved ejection fraction
by: A. N. Kaburova, et al.
Published: (2022-10-01)

Association of advanced lung cancer inflammation index with all-cause and cardiovascular mortality in US patients with asthma
by: Jiatao Li, et al.
Published: (2025-06-01)

The multifaceted roles of mucins family in lung cancer: from prognostic biomarkers to promising targets
by: Qinghong Yuan, et al.
Published: (2025-06-01)

Low-intensity inflammation as a manifestation of comorbidity and a factor in the unfavorable clinical course of heart failure with preserved ejection fraction
by: K. N. Vitt, et al.
Published: (2024-03-01)